Treatment or prophylaxis of retinal pathology and spinal cord injury
US6159958A · kind A · utility
1Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 13, 1998 |
| Grant date | Dec 12, 2000 |
| Priority date | — |
| Expiry date | Aug 13, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions containing 2-(phosphonomethyl)-pentanedioic acid (PMPA) and pha. and .beta. N-acetyl-aspartyl-glutamate (NAAG) are appropriate means for treatment of neuronal tissue injury that may result from such factors as injury, toxicity, hypoxia or ischemia (a frequent cause of hypoxia). Target tissues include the brain, spinal cord and retina.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.